Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other


Tags
Quarterly results

AGIOS PHARMACEUTICALS, INC. (AGIO) Create: Alert

All | News | Filings
Date FiledTypeDescription
08/03/2023 8-K Quarterly results
Docs: "Agios Reports Business Highlights and Second Quarter 2023 Financial Results –Announced Positive Results from Phase 2 Portion of the RISE UP Pivotal Study of Mitapivat in Sickle Cell Disease&#59; On Track to Enroll First Patient in Phase 3 Portion of the Study in Q4 2023"
02/23/2023 8-K Quarterly results
Docs: "Agios Reports Fourth Quarter and Full Year 2022 Financial Results – Completed Enrollment in Phase 2 RISE UP Study of PYRUKYND® in Sickle Cell Disease –"
11/03/2022 8-K Quarterly results
08/04/2022 8-K Quarterly results
05/05/2022 8-K Quarterly results
02/24/2022 8-K Quarterly results
11/03/2021 8-K Quarterly results
Docs: "UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549",
"Agios Reports Business Highlights and Third Quarter 2021 Financial Results"
07/29/2021 8-K Quarterly results
Docs: "UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549",
"Agios Reports Business Highlights and Second Quarter 2021 Financial Results"
02/25/2021 8-K Quarterly results
11/05/2020 8-K Quarterly results
Docs: "UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549",
"Agios Reports Business Highlights and Third Quarter 2020 Financial Results"
07/30/2020 8-K Quarterly results
04/30/2020 8-K Quarterly results
Docs: "Agios Reports First Quarter 2020 Financial Results and Provides Update on Business Operations and COVID-19 Response"
02/13/2020 8-K Quarterly results
10/31/2019 8-K Quarterly results
08/01/2019 8-K Quarterly results
Docs: "UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549",
"Agios Reports Business Highlights and Second Quarter 2019 Financial Results"
05/02/2019 8-K Quarterly results
Docs: "UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15 of the Securities Exchange Act of 1934 Date of Report : May 2, 2019 Agios Pharmaceuticals, Inc. Delaware 001-36014 26-0662915 88 Sidney Street, Cambridge, MA 02139 Registrant's telephone number, including area code: 649-8600",
"Agios Reports Business Highlights and First Quarter 2019 Financial Results"
02/14/2019 8-K Quarterly results
11/01/2018 8-K Quarterly results
Docs: "UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15 of the Securities Exchange Act of 1934 Date of Report : November 1, 2018 Agios Pharmaceuticals, Inc. Delaware 001-36014 26-0662915 88 Sidney Street, Cambridge, MA 02139 Registrant's telephone number, including area code: 649-8600",
"Agios Reports Third Quarter 2018 Financial Results"
08/02/2018 8-K Quarterly results
Docs: "FORM 8-K",
"Agios Reports Second Quarter 2018 Financial Results"
02/14/2018 8-K Quarterly results
Docs: "FORM 8-K",
"Agios Reports Fourth Quarter and Full Year 2017 Financial Results"
08/08/2017 8-K Quarterly results
Docs: "Agios Reports Second Quarter 2017 Financial Results"
05/04/2017 8-K Form 8-K - Current report
02/16/2017 8-K Form 8-K - Current report
11/03/2016 8-K Form 8-K - Current report
08/04/2016 8-K Form 8-K - Current report
05/05/2016 8-K Form 8-K - Current report
02/18/2016 8-K Form 8-K - Current report
11/05/2015 8-K Quarterly results
Docs: "Agios Reports Third Quarter 2015 Financial Results"
08/06/2015 8-K Quarterly results
Docs: "Agios Reports Second Quarter 2015 Financial Results and Provides Updates on Clinical Development Progress"
05/07/2015 8-K Quarterly results
Docs: "Agios Reports First Quarter 2015 Financial Results and Outlines Late-Stage Clinical Development for AG-221 and AG-120"
02/17/2015 8-K Quarterly results
Docs: "Agios Pharmaceuticals Reports Fourth Quarter and Full Year 2014 Financial Results"
11/07/2014 8-K Quarterly results
Docs: "Agios Pharmaceuticals Reports Third Quarter 2014 Financial Results"
08/07/2014 8-K Quarterly results
Docs: "Agios Pharmaceuticals Reports Second Quarter 2014 Financial Results"
05/08/2014 8-K Quarterly results
Docs: "Agios Pharmaceuticals Reports First Quarter 2014 Financial Results"
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy